nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Activated factor VIII-mimicking effect by emicizumab on thrombus formation in type 2N von Willebrand disease under high shear flow conditions
|
Yaoi, Hiroaki |
|
|
198 |
C |
p. 7-16 |
artikel |
2 |
Association of anticoagulation use with SARS-CoV2 detection
|
Kavecansky, Juraj |
|
|
198 |
C |
p. 99-102 |
artikel |
3 |
Biomarker association with cardiovascular disease and mortality – The role of fibrinogen. A report from the NHANES study
|
Pieters, Marlien |
|
|
198 |
C |
p. 182-189 |
artikel |
4 |
Challenging anticoagulation cases: A case of acute pulmonary embolism in a patient with chronic thrombocytopenia
|
de Wit, Kerstin |
|
|
198 |
C |
p. 83-85 |
artikel |
5 |
Deep vein thrombosis in a tertiary hospital from Ethiopia
|
Amare, Hiwot |
|
|
198 |
C |
p. 17-18 |
artikel |
6 |
Discordance in activated partial thromboplastin time and anti-factor Xa levels in COVID-19 patients on heparin therapy
|
Lawlor, Matthew |
|
|
198 |
C |
p. 79-82 |
artikel |
7 |
Editorial Board
|
|
|
|
198 |
C |
p. IFC |
artikel |
8 |
Elevated anti-human factor Xa activity in rabbit and rodent plasma: Implications for preclinical assessment of human factor X in animal models of hemostasis
|
Verhoef, Daniël |
|
|
198 |
C |
p. 154-162 |
artikel |
9 |
Glycation and acetylation sites on fibrinogen in plasma fibrin clot of patients with type 2 diabetes: Effects of low-dose acetylsalicylic acid
|
Bryk, Agata Hanna |
|
|
198 |
C |
p. 93-98 |
artikel |
10 |
How significant is the antifibrinolytic effect of lipoprotein(a) for blood clot lysis?
|
Rijken, Dingeman C. |
|
|
198 |
C |
p. 210-212 |
artikel |
11 |
Immature platelet dynamics correlate with ADAMTS13 deficiency and predict therapy response in immune-mediated thrombotic thrombocytopenic purpura
|
Zhu, Meng-Lei |
|
|
198 |
C |
p. 72-78 |
artikel |
12 |
Impact of uric acid on immature platelet fraction in patients undergoing percutaneous coronary intervention
|
Nardin, Matteo |
|
|
198 |
C |
p. 171-181 |
artikel |
13 |
Incidence of inhibitor development in PUPs with severe Haemophilia A in the CEE region between 2005 and 2015
|
Blatný, Jan |
|
|
198 |
C |
p. 196-203 |
artikel |
14 |
Incidence of symptomatic venous thromboembolism following hospitalization for coronavirus disease 2019: Prospective results from a multi-center study
|
Rashidi, Farid |
|
|
198 |
C |
p. 135-138 |
artikel |
15 |
Influence of low body weight on long-term clinical outcomes in patients with venous thromboembolism: From the COMMAND VTE registry
|
Kaneda, Kazuhisa |
|
|
198 |
C |
p. 26-33 |
artikel |
16 |
Is chemoprophylaxis required after total knee and total hip arthroplasty in the Asian population? A systematic review and network meta-analysis
|
Xu, Sheng |
|
|
198 |
C |
p. 86-92 |
artikel |
17 |
Links between thrombosis and inflammation in traumatic brain injury
|
Hubbard, W. Brad |
|
|
198 |
C |
p. 62-71 |
artikel |
18 |
Low molecular weight heparin and 28-day mortality among patients with coronavirus disease 2019: A cohort study in the early epidemic era
|
Qin, Wei |
|
|
198 |
C |
p. 19-22 |
artikel |
19 |
Opinion and practice survey about the use of prognostic models in acute pulmonary embolism
|
Elias, Antoine |
|
|
198 |
C |
p. 40-48 |
artikel |
20 |
Platelet electrical resistance for measuring platelet activation and adhesion in human health and disease
|
Griffiths, Travis M. |
|
|
198 |
C |
p. 204-209 |
artikel |
21 |
Possible immune regulation mechanisms for the progression of chronic thromboembolic pulmonary hypertension
|
Miao, Ran |
|
|
198 |
C |
p. 122-131 |
artikel |
22 |
Prevalence of definite antiphospholipid syndrome in carriers of the JAK2 V617F mutation
|
Janjetovic, Snjezana |
|
|
198 |
C |
p. 55-61 |
artikel |
23 |
Primary antiphospholipid syndrome revealed by acute myocardial infarction in young adults: a prospective observational study
|
Chezel, Julie |
|
|
198 |
C |
p. 151-153 |
artikel |
24 |
Pulmonary embolism in COVID-19 patients: prevalence, predictors and clinical outcome
|
Scudiero, Fernando |
|
|
198 |
C |
p. 34-39 |
artikel |
25 |
P2Y12 inhibitor monotherapy and dual antiplatelet therapy after percutaneous coronary intervention: An updated meta-analysis of randomized trials
|
Jin, Yao |
|
|
198 |
C |
p. 115-121 |
artikel |
26 |
Safety and effectiveness of apixaban compared with warfarin among clinically-relevant subgroups of venous thromboembolism patients in the United States Medicare population
|
Guo, Jennifer D. |
|
|
198 |
C |
p. 163-170 |
artikel |
27 |
The novel mutation p.Asp315Tyr causes severe hemophilia B by impairing coagulation factor IX expression
|
Lu, Zhengjing |
|
|
198 |
C |
p. 23-25 |
artikel |
28 |
Thrombotic antiphospholipid syndrome: A practical guide to diagnosis and management
|
Sayar, Zara |
|
|
198 |
C |
p. 213-221 |
artikel |
29 |
Translational insight into prothrombotic state and hypercoagulation in nonalcoholic fatty liver disease
|
Ciavarella, Alessandro |
|
|
198 |
C |
p. 139-150 |
artikel |
30 |
Type 2N von Willebrand disease: Is it always a recessive trait?
|
Woods, Adriana Inés |
|
|
198 |
C |
p. 49-51 |
artikel |
31 |
Use and outcomes of prothrombin complex concentrate for factor Xa inhibitor-associated bleeding
|
Frank, Annabel K. |
|
|
198 |
C |
p. 132-134 |
artikel |
32 |
Using oral anticoagulants among chronic kidney disease patients to prevent recurrent venous thromboembolism: A systematic review and meta-analysis
|
Alhousani, Mohammad |
|
|
198 |
C |
p. 103-114 |
artikel |
33 |
Venous thromboembolism in renal transplant recipients: Results of Venous thromboEmbolism in renal Transplant Recipients- Italian Study - VETRIS
|
Poli, Daniela |
|
|
198 |
C |
p. 52-54 |
artikel |
34 |
Von Willebrand factor in aortic or mitral valve stenosis and bleeding after heart valve surgery
|
Mazur, Piotr |
|
|
198 |
C |
p. 190-195 |
artikel |
35 |
Weight-adjusted tinzaparin for venous thromboembolism prophylaxis in bariatric surgery patients weighing 160 kg or more
|
Li, A. |
|
|
198 |
C |
p. 1-6 |
artikel |